Weinstein Boaz

Saba Capital, 10% owner, bought 50,351 shares at $40.17 avg on Sep 9-10, adding 1.2% to 4.31M holdings

Saba Capital Management completed two open-market purchases totaling 50,351 shares for $2,022,416.34 ($2.0M) at an average price of $40.17 on September 9–10, increasing its stake from 4,260,544 shares to 4,310,895 shares (4.31M shares), a +1.2% increase. The current price of $40.71 stands at the 52-week high, with the stock up 15.5% over 30 days and 18.7% over 90 days. Saba's cross-ticker track record shows 10 prior buys and 10 prior sells; however, the same-ticker history at ASA reveals five consecutive buy transactions on September 3–11 with outcomes not yet measurable. The incremental purchase maintains the existing large block position during a period of significant upward momentum rather than accumulation at depressed levels.

Saba Capital Management sells 186,311 shares of ECAT at $16.69–$16.70 (Sep 9–10); holdings remain 27.88M shares post-sale.

Saba Capital Management, a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), completed 2 separate sales totaling 186,311 shares for $3,110,629.54 at a blended average price of $16.70 across September 9–10, 2025. This represents a -0.7% reduction in holdings (from 28.07M to 27.88M shares). The sales occurred at prices near the current level ($16.80 is 0.6% above the transaction blended average) and within the 52-week range ($13.91–$18.07), with the stock currently 7.0% below its 52-week high. Notably, Saba has engaged in 5 consecutive sales at ECAT over a 6-day window (September 2–8, with these filings for Sep 9–10), though outcomes from the prior four sales are not yet measurable at 30 and 90 days; across all tickers, Saba's track record shows 12 prior buys against 8 prior sells, providing limited directional signal from past timing accuracy. The incremental reduction in a concentrated position warrants observation of whether the pattern continues or reflects scheduled rebalancing within the fund family.

10% owner Saba Capital buys 68,449 DMA shares at $8.60; second buy in 4 days.

Saba Capital Management, L.P., a 10% owner of Destra Multi-Alternative Fund, purchased 68,449 shares at $8.60 on 2025-09-09, the second open-market buy in as many days (prior buy on 2025-09-08). This incremental accumulation lifted holdings from 2,166,695 to 2,235,144 shares, a +3.2% increase. The current price of $8.80 sits 3.3% below the 52-week high of $9.10, placing this trade neither at a notable valuation extreme nor at a 52-week low. Across Saba's cross-ticker track record, 11 prior buys and 9 prior sells show balanced activity without a demonstrable edge in timing outcomes. The consecutive-day purchasing pattern and modest accumulation size provide limited basis for inferring directional conviction at this juncture.

Saba Capital sells 136,042 BFZ shares at $10.69; holds 3.11M shares post-sale

Saba Capital Management executed a sale of 136,042 shares on 2025-09-08 at $10.69, representing a -4.2% reduction from its prior 3.24M share position. This is the third consecutive sale at BFZ within three days (prior sales on 2025-09-05 and 2025-09-04), suggesting a deliberate unwinding rather than a single-event transaction. The current price of $10.75 is -11.9% from the 52-week high and trading in the lower half of the 52-week range of $10.20–$12.20. Across Saba's open-market history, the insider's cross-ticker track record shows 11 prior buys and 9 prior sells, indicating a balanced approach; however, no prior sells at BFZ have reached measurable 90-day outcomes yet, so this pattern of three consecutive sales lacks precedent in the same-ticker record for outcome validation.

Saba Capital (10% owner) bought 24,510 shares of ASA at $40.50 on 2025-09-08, total $992,655.

Saba Capital Management purchased 24,510 shares at $40.50, increasing holdings from 4,236,034 to 4,260,544 shares, a modest 0.6% addition to its 10% stake. The purchase occurred near the 52-week high ($40.47), just 1.3% below the peak, following a 13.8% rally over 30 days and 21.3% over 90 days. The insider's cross-ticker buy-sell track record shows equal activity (10 prior buys, 10 prior sells across all tickers), providing no directional conviction signal, and the same-ticker history at ASA shows five recent consecutive buys (all since 2025-09-02) whose outcomes remain unmeasurable. The transaction represents incremental accumulation during an already-elevated price period rather than a contrarian entry point.

Saba Capital Management sold 79,152 shares of ECAT at $16.66 on 2025-09-08; maintains 28.07M shares (99.7% of holdings).

Saba Capital Management, a 10% owner, sold 79,152 shares valued at $1.3M, reducing holdings by only 0.3% to 28.07M shares. The sale occurred at $16.66, near the current price of $16.70, within the 52-week range of $13.91–$18.07. This represents a minor position adjustment rather than a material exit; the 10% ownership stake remains intact. Notably, Saba executed five sequential sells at ECAT between 2025-09-02 and 2025-09-09, suggesting a modest liquidation pattern, though the cumulative impact on voting control appears immaterial. The cross-ticker track record shows 11 prior buys and 9 prior sells, providing limited directional signal for this transaction.

Saba Capital bought 500 DMA shares at $8.58 on 2025-09-08; 2.17M shares held post-transaction.

Saba Capital Management, a 10% owner, purchased 500 shares of Destra Multi-Alternative Fund (DMA) at $8.58, a price 0.8% below the current $8.65 level and 5.7% below the 52-week high of $9.10. The transaction increased holdings from 2.17M shares to 2.17M shares, representing a net addition of 500 shares (+0.0% change). The cross-ticker track record shows 10 prior buys and 10 prior sells with no measurable timing advantage at the 90-day mark. Prior trades at DMA (2 buys on 2025-09-09 and 2025-09-05) do not yet have measurable 30-day or 90-day outcomes. The modest share acquisition and immaterial percentage change to holdings suggest routine incremental activity rather than a material conviction signal.

Saba Capital Management (10% owner) sold 367,416 shares of BFZ for $3,881,500.97; holdings reduced from 3.61M to 3.24M shares.

Saba Capital Management executed 2 separate sales totaling 367,416 shares for $3,881,500.97 at a blended average price of $10.56 on September 4–5, 2025, reducing its stake by 10.2% to 3,243,450 shares. The current price of $10.70 is 12.3% below the 52-week high of $12.20, placing the sale near the lower end of the annual range. Across the insider's cross-ticker history, there are 12 prior buys and 8 prior sells, but same-ticker timing outcomes at BFZ are not yet measurable. The sales represent a material reduction in an already significant 10% shareholder position, warranting investor monitoring of any accompanying disclosures regarding intent or market outlook.

Saba Capital (10% owner) purchased 33,459 shares across 2 transactions for $1,295,170.80, expanding stake to 4.24M shares at blended avg $38.71 vs current $40.47.

Saba Capital Management, L.P. executed 2 separate purchases totaling 33,459 shares for $1,295,170.80 at an average price of $38.71, with the current price now at $40.47. As a 10% shareholder, this modest 0.8% increase in holdings occurs against a backdrop of strong recent price momentum: ASA shares are up 15.2% over 30 days and 21.4% over 90 days, now trading at the 52-week high of $40.47. The timing of these purchases falls within a recent cluster of 5 consecutive buy transactions at ASA between 2025-08-28 and 2025-09-08, suggesting sustained conviction. However, across Saba's broader open-market history spanning all tickers, the track record shows balanced activity (10 prior buys, 10 prior sells) with no pattern of well-timed buy execution at the 90-day mark, so this transaction should be evaluated on its fundamental merits rather than as a signal of market-beating timing insight.

Saba Capital (10% owner) sells 158,768 shares of ECAT in 2 transactions for $2,628,284.13 at $16.55 average price

Saba Capital, a 10% owner, executed two separate sales totaling 158,768 shares for $2,628,284.13 on September 4–5, 2025, reducing holdings by 0.6% from 28.30M to 28.14M shares. The sales occurred near the 52-week high ($18.07), with the blended average price of $16.55 within the current 52-week range of $13.91–$18.07. Notably, this filing represents the fifth consecutive sell transaction at ECAT within a 12-day window (August 28 through September 8), suggesting a sustained reduction in position rather than an isolated adjustment. The cumulative pattern of repeated selling at this ticker warrants tracking of whether this reflects planned position management or shifting portfolio views.